Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found one record

$72,000.00

Apr 1, 2018

For-profit organization

Agreement:

Development of Pharmacological Compounds to Overcome Respiratory Depression

Agreement Number:

904073

Duration: from Apr 1, 2018 to Apr 30, 2019
Description:

The Firm is developing a pharmacological therapy using drugs that target the alpha2beta2 subtype of nicotonic acetylcholine receptor to counter respiratory depression associated with opiates (e.g. fentanyl), propofol, alcohol, barbiturates, apnea of prematurity, obstructive and central sleep apnea, brain and spinal cord damage, and genetic disorders affecting breathing (e.g. Pompe Disease). They will perform a systematic series of pre-clinical studies using rodent models to determine the most effective candidate compounds to be tested in early stage clinical trials.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Edmonton, Alberta, CA T5R 3P2